Posted under Startups
from http://venturebeat.com/ 1105 days ago

SPONSORED POST


Check out our press release hub, powered by Business Wire. It's a one stop shop for industry announcements to help you stay on top of the latest technology and investment trends. Get the scoop here.

BOSTON–(BUSINESS WIRE)–August 6, 2014–

The management of Boston Millennia Partners is pleased to announce that two recent liquidity events, the sale of Precision Dermatology, Inc. and CardioMEMS, Inc., have created $105 million of value for its Limited Partners.

With the receipt of Hart-Scott-Rodino clearance, the previously announced acquisition of Precision Dermatology by Valeant Pharmaceuticals, Inc. for $500 million, closed July 7, 2014. On May 30, Boston Millennia Partners’ portfolio company CardioMEMS, Inc., whose lead product is a significant advancement in the treatment of heart failure, was sold to St. Jude Medical pursuant to a transaction valued at $463 million.

Precision was spun out of Collegium Pharmaceuticals, a specialty pharmaceuticals company ...

Read More...

blog comments powered by Disqus
Editor's Pick
Popular Today